SPY001, An Anti-α4β7, Shows Promise in Phase 2 SKYLINE Trial for Ulcerative Colitis - HCPLive

SPY001, An Anti-α4β7, Shows Promise in Phase 2 SKYLINE Trial for Ulcerative Colitis - HCPLive

Published: Sunday, June 7, 2026 11:01 PM

                        SPY001, An Anti-a4ß7, Shows Promise in Phase 2 SKYLINE Trial for Ulcerative Colitis  HCPLive
                    

URL: Click for website